Blood cancer patients face higher clot risk from COVID

NCT ID NCT04385160

Completed Knowledge-focused Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This study looked at 552 adults with myeloproliferative neoplasms (MPN), a type of blood cancer, who also got COVID-19. Researchers wanted to see how often these patients developed dangerous blood clots, like pulmonary embolism. The goal was to understand what factors make COVID-19 worse for people with MPN.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

A.O.U. Città della Salute e della Scienza di Torino

Torino, 10126, Italy
A.S.O. SS. Antonio e Biagio e C.Arrigo di Alessandria

Alessandria, 15121, Italy
AOU Ospedale Careggi

Florence, 50134, Italy
ASST-Papa Giovanni XXIII

Bergamo, 24127, Italy
ASST-Spedali Civili

Brescia, 25123, Italy
Azienda Ospedaliero Universitaria Maggiore della Carità

Novara, 28100, Italy
FEA Hematología Hospital Universitario de Móstoles

Madrid, Spain
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Milan, 20122, Italy
Guy's and St. Thomas' NHS Foundation Trust.

London, United Kingdom
Hopital Saint-Louis

Paris, France
Hospital 12 de octubre

Madrid, Spain
Hospital Clínic De Barcelona

Barcelona, Barcellona, Spain
Hospital Clínico San Carlos

Madrid, Spain
Hospital Clínico Universitario

Valencia, Spain
Hospital General de Elche

Alicante, Spain
Hospital General de La Palma

Breña Alta, Santa Cruz De Tenerife, Spain
Hospital Gregorio Marañón

Madrid, Spain
Hospital Moncloa

Madrid, Spain
Hospital Ramón y Cajal

Madrid, Spain
Hospital Universitario Infanta Leonor

Madrid, Spain
Hospital Universitario La Paz

Madrid, Spain
Hospital Universitario Príncipe de Asturias

Alcalá de Henares, Madrid, Spain
Hospital Universitario de Burgos

Burgos, Spain
Hospital Vall d'Hebron

Barcelona, Spain
Hospital del Mar

Barcelona, Barcellona, Spain
ICO Girona Hospital Josep Trueta Servei d'hematologia

Girona, Spain
ICO L'Hospitalet - Hospital Moisès Broggi

Sant Joan Despí, Barcelona, Spain
IRCCS Ospedale San Raffaele

Milan, 20132, Italy
IRCCS Policlinico San Matteo

Pavia, 27100, Italy
Institut Català d' Oncologia - Hospital Germans Trias i Pujol

Badalona, Barcelona, Spain
National Specialised Hospital for Active Treatment of Hematological Diseases

Sofia, Bulgaria
New York-Presbyterian/Weill Cornell Medical Center

New York, New York, 10065, United States
Ospedale Policlinico "G.B. Rossi" Borgo Roma

Verona, 37134, Italy
Ospedale San Bortolo

Vicenza, 36100, Italy
Ospedale San Gerardo di Monza

Monza, Monza Brianza, 20900, Italy
Policlinico S.Orsola-Malpighi

Bologna, 40138, Italy
Policlinico Universitario Fondazione Agostino Gemelli

Roma, 00168, Italy
Servicio de Hematología Hospital General Universitario de Albacete

Albacete, Spain
Sobas Wroclaw Medical University ·

Wroclaw, Poland
University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center

Minden, Germany
University Hospital Halle, Department of Hematology/Oncology

Halle, Saale, 06112, Germany
University Medical Center RWTH

Aachen, Germany
University Medicine Greifswald - Hematology, Oncology, Stem Cell Transplantation and Palliative Care

Greifswald, 17475, Germany
University hospital Dubrava-School of Medicine University of Zagreb

Zagreb, Croatia

Conditions

Explore the condition pages connected to this study.

COVID MYELOPROLIFERATIVE NEOPLASM